Shorts about to lose a lot of money over the next few months.
Consistently beating revenue projections will move the pps up. Don't look for buyout until 2015 and I don't see any way this company will go for less than 20 with the potential of micronized Amniofix in addition to surgical applications of Epifix/Amniofix. There are other products in the pipeline like vascular shield and collagen laced with antifungal for long term slow release. You have to feel a bit sorry for the shorts :)